US Equities Analysis

WAT — Waters Corporation

WAT Price Chart

Waters Corporation (WAT) is a life sciences tools & services company in the Health Care sector. Listed on the NASDAQ, Waters Corporation is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $363.18.

Key Metrics & Risk

Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).

MetricValue
Latest Price$363.18
Latest Date2026-06-10
Expected Return (Annualized)7.14%
Risk / Std Dev (Annualized)33.59%
Sharpe Ratio (rf=4.5%)0.08

S&P 500 Context

  • Sector: Health Care
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Index: S&P 500 Component

Risk/Return Profile

The stock shows an annualized expected return of 7.14% with an annualized volatility of 33.59%. The Sharpe ratio of 0.08 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.

Modern Portfolio Theory Positioning

This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.

Fundamentals

MetricValue
Market Cap35.66B
Enterprise Value40.8B
Trailing P/E46.32
Forward P/E22.05
Price to Book8.44
Price to Sales9.46
EV/Revenue10.82
EV/EBITDA35.95

| Profitability | | | Profit Margin | 11.93% | | Operating Margin | 2.84% | | ROE | 5.21% | | ROA | 3.31% |

| Growth | | | Revenue Growth | 91.4% |

| Financial Health | | | Total Revenue | 3.77B | | Total Debt | 5.6B | | Total Cash | 0.46B | | Free Cash Flow | -0.5B | | Operating Cash Flow | 0.39B |

| Price & Technical | | | 52W High | $414.15$ | | 52W Low | $275.05$ | | 50-Day Avg | $333.03$ | | 200-Day Avg | $342.7$ | | Beta | 1.2 | | Shares Outstanding | 0.1B | | Float Shares | 0.1B | | Insider Holdings | 0.1% | | Institutional Holdings | 99.65% | | Short Ratio | 3.66 | | Short % of Float | 4.56% |

| Analyst Targets | | | Target High | $460.0$ | | Target Low | $345.0$ | | Target Mean | $400.29$ | | Target Median | $400.0$ | | # of Analysts | 21 | | Recommendation | buy |

Disclaimer

This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.

us-equity stock equity wat health-care life-sciences-tools--services nasdaq